The European Research Network on Signal Transduction (ERNEST): Toward a Multidimensional Holistic Understanding of G Protein-Coupled Receptor Signaling
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
The European Research Network on Signal Transduction (ERNEST) : Toward a Multidimensional Holistic Understanding of G Protein-Coupled Receptor Signaling. / Sommer, Martha E; Selent, Jana; Carlsson, Jens; De Graaf, Chris; Gloriam, David E; Keseru, Gyorgy M; Kosloff, Mickey; Mordalski, Stefan; Rizk, Aurelien; Rosenkilde, Mette M.; Sotelo, Eddy; Tiemann, Johanna K. S.; Tobin, Andrew; Vardjan, Nina; Waldhoer, Maria; Kolb, Peter.
In: ACS Pharmacology & Translational Science, Vol. 3, No. 2, 2020, p. 361-370.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The European Research Network on Signal Transduction (ERNEST)
T2 - Toward a Multidimensional Holistic Understanding of G Protein-Coupled Receptor Signaling
AU - Sommer, Martha E
AU - Selent, Jana
AU - Carlsson, Jens
AU - De Graaf, Chris
AU - Gloriam, David E
AU - Keseru, Gyorgy M
AU - Kosloff, Mickey
AU - Mordalski, Stefan
AU - Rizk, Aurelien
AU - Rosenkilde, Mette M.
AU - Sotelo, Eddy
AU - Tiemann, Johanna K. S.
AU - Tobin, Andrew
AU - Vardjan, Nina
AU - Waldhoer, Maria
AU - Kolb, Peter
N1 - Copyright © 2020 American Chemical Society.
PY - 2020
Y1 - 2020
N2 - G protein-coupled receptors (GPCRs) are intensively studied due to their therapeutic potential as drug targets. Members of this large family of transmembrane receptor proteins mediate signal transduction in diverse cell types and play key roles in human physiology and health. In 2013 the research consortium GLISTEN (COST Action CM1207) was founded with the goal of harnessing the substantial growth in knowledge of GPCR structure and dynamics to push forward the development of molecular modulators of GPCR function. The success of GLISTEN, coupled with new findings and paradigm shifts in the field, led in 2019 to the creation of a related consortium called ERNEST (COST Action CA18133). ERNEST broadens focus to entire signaling cascades, based on emerging ideas of how complexity and specificity in signal transduction are not determined by receptor-ligand interactions alone. A holistic approach that unites the diverse data and perspectives of the research community into a single multidimensional map holds great promise for improved drug design and therapeutic targeting.
AB - G protein-coupled receptors (GPCRs) are intensively studied due to their therapeutic potential as drug targets. Members of this large family of transmembrane receptor proteins mediate signal transduction in diverse cell types and play key roles in human physiology and health. In 2013 the research consortium GLISTEN (COST Action CM1207) was founded with the goal of harnessing the substantial growth in knowledge of GPCR structure and dynamics to push forward the development of molecular modulators of GPCR function. The success of GLISTEN, coupled with new findings and paradigm shifts in the field, led in 2019 to the creation of a related consortium called ERNEST (COST Action CA18133). ERNEST broadens focus to entire signaling cascades, based on emerging ideas of how complexity and specificity in signal transduction are not determined by receptor-ligand interactions alone. A holistic approach that unites the diverse data and perspectives of the research community into a single multidimensional map holds great promise for improved drug design and therapeutic targeting.
U2 - 10.1021/acsptsci.0c00024
DO - 10.1021/acsptsci.0c00024
M3 - Journal article
C2 - 32296774
VL - 3
SP - 361
EP - 370
JO - ACS Pharmacology and Translational Science
JF - ACS Pharmacology and Translational Science
SN - 2575-9108
IS - 2
ER -
ID: 240247736